New York accuses Insys of deceptively marketing opioid | | (Reuters) - Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses. | | | India's 'Modicare' to cost about $1.7 billion a year: sources | | NEW DELHI (Reuters) - Indian Prime Minister Narendra Modi's plan to provide health insurance for about half the country's population would require an estimated 110 billion rupees ($1.7 billion) in federal and state funding each year, sources familiar with the matter said. | | | Two U.S. lawmakers voice concerns over Philip Morris tobacco trials | | WASHINGTON (Reuters) - Two Democratic U.S. senators said they have fresh concerns over clinical trials conducted by Philip Morris International Inc as it seeks U.S. clearance to market its iQOS electronic tobacco product as less risky than cigarettes, according to statements both senators provided to Reuters. | | | Soaring demand for female genital surgery sparks debate in Brazil | | RIO DE JANEIRO (Reuters) - In Brazil, a country famed for its obsession with the body beautiful, women are increasingly opting for surgery aimed at improving the appearance of their genitals, stirring a debate about sexual empowerment and the pressure for physical perfection. | | | | | | | | Related Video | | | | | | | | | | | A quick-fix on the day's news delivered when you want it. Register Today | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | » » MORE NEWSLETTERS | | |